- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07765771
Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee Arthroplasty (MISI)
Comparison of a Minimal Incision and Minimal Soft-Tissue Injury (MISI) Technique Versus the Standard Technique in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Robotic-assisted total knee arthroplasty requires surgical exposure and placement of tracking pins. Conventional techniques may involve a relatively long incision, broader soft-tissue dissection, and diaphyseal pin insertion. The MISI technique was developed to reduce surgical invasiveness through a shorter incision, limited soft-tissue dissection, and modified tracking pin placement that avoids diaphyseal pin insertion.
Participants will be randomly assigned to the MISI or standard technique in a 1:1 ratio. Clinical evaluations will be performed during follow-up for up to 12 months. The study will assess whether the MISI technique improves scar-related outcomes and early recovery without increasing procedure-related complications.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Ho-Jung Jung, MD, PhD
- Telefonnummer: 82-02-819-5165
- E-Mail: hodge@hallym.or.kr
Studienorte
-
-
-
Seoul, Südkorea
- Hallym University Kangnam Sacred Heart Hospital
-
Kontakt:
- Ho-Jung Jung, MD, PhD
- Telefonnummer: 82-02-819-5165
- E-Mail: hodge@hallym.or.kr
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Adults aged 18 years or older
- Degenerative knee osteoarthritis requiring robotic-assisted total knee arthroplasty
- Body mass index below 30 kg/m²
- Preoperative knee flexion of 90 degrees or greater
- Ability to understand the study information and provide written informed consent
Exclusion Criteria:
- Skin lesions or conditions that may adversely affect wound healing
- Previous intra-articular surgery of the affected knee
- Inflammatory arthritis, including rheumatoid arthritis
- Severe hepatic or renal disease associated with poor general health
- Comorbid conditions that may substantially affect mobility, including Parkinson disease, sequelae of poliomyelitis, or stroke
- Inability or unwillingness to complete the required follow-up
- Any medical or other condition that, in the investigator's judgment, makes participation inappropriate
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: MISI tenchique
Participants will undergo robotic-assisted total knee arthroplasty using the minimal incision and minimal soft-tissue injury (MISI) technique.
The procedure uses an approximately 10-cm main incision with limited soft-tissue dissection.
Two femoral tracking pins are inserted through the main incision, and one tibial tracking pin is inserted through an additional approximately 5-mm incision.
|
Robot-assisted total knee arthroplasty performed using an approximately 10-cm main incision, limited soft-tissue dissection, two femoral tracking pins inserted through the main incision, and one tibial tracking pin inserted through an additional approximately 5-mm incision.
|
|
Aktiver Komparator: Standard technique
Participants will undergo robotic-assisted total knee arthroplasty using the standard surgical technique.
Tracking arrays are secured using the conventional pin placement method, with four tracking pins placed in the femoral and tibial regions and an additional femoral incision.
|
Robot-assisted total knee arthroplasty performed using the standard incision and soft-tissue exposure, with conventional placement of four tracking pins in the femoral and tibial regions and an additional femoral incision.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Zeitfenster: 3 months after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 months after surgery
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Zeitfenster: 3 and 6 weeks after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 and 6 weeks after surgery
|
|
Main Surgical Incision Length
Zeitfenster: During surgery and on postoperative day 1
|
The length of the main surgical incision will be measured in centimeters.
The initial incision length will be measured immediately after the skin incision with the knee in extension, and the final incision length will be measured before wound closure.
The incision length will also be evaluated on postoperative day 1.
Separate tracking pin-site incisions will not be included.
|
During surgery and on postoperative day 1
|
|
Intraoperative Incision Stretching Index
Zeitfenster: During surgery
|
The incision stretching index is calculated as the maximum length of the main incision during knee flexion and maximal surgical retraction divided by the initial incision length measured with the knee in extension.
A value of 1 indicates no stretching, and higher values indicate greater intraoperative stretching of the incision and surrounding soft tissue.
|
During surgery
|
|
Postoperative Gauze Oozing Grade
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
Postoperative wound oozing will be assessed according to the amount of blood or exudate visible on the surgical dressing using a prespecified ordinal grading scale.
Higher grades indicate more extensive wound oozing.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain at Rest on the Numeric Rating Scale
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain at rest using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain During Active Hip Flexion on the Numeric Rating Scale
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain during active hip flexion while maintaining knee extension and without external resistance.
Pain will be assessed using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Tenderness at the Standardized Tracking Pin-Site Location
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
Tenderness elicited by palpation at a prespecified standardized anatomical location corresponding to the tracking pin region will be rated using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no tenderness and 10 indicates the worst imaginable tenderness.
|
Postoperative days 1, 2, 4, and 6
|
|
Ability to Perform Straight-Leg Raising
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
The participant's ability to independently raise the operated lower extremity while maintaining knee extension will be recorded as a binary outcome: able or unable to perform straight-leg raising.
The number and proportion of participants able to perform the test will be compared between groups.
|
Postoperative days 1, 2, 4, and 6
|
|
Pain During the Resisted Straight-Leg-Raising Test
Zeitfenster: Postoperative days 1, 2, 4, and 6
|
Pain during resisted straight-leg raising will be assessed using a 100-mm visual analog scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Incidence of Tracking Pin-Site Complications
Zeitfenster: Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
Tracking pin sites will be examined for complications, including erythema, swelling, wound drainage, infection, and pin-related fracture.
The occurrence of one or more prespecified pin-site complications will be recorded as a binary outcome, and the number and proportion of participants with any complication will be reported.
|
Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
|
Forgotten Joint Score-12
Zeitfenster: 6 and 12 months after surgery
|
The Forgotten Joint Score-12 is a 12-item patient-reported questionnaire assessing awareness of the operated knee during daily activities.
Scores are transformed to a scale ranging from 0 to 100, with higher scores indicating less awareness of the artificial joint and a better outcome.
|
6 and 12 months after surgery
|
|
Western Ontario and McMaster Universities Osteoarthritis Index
Zeitfenster: 6 and 12 months after surgery
|
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assesses knee pain, stiffness, and physical function.
The 24 items are scored using a 5-point Likert scale, producing a total score ranging from 0 to 96.
Higher scores indicate more severe symptoms and poorer physical function.
|
6 and 12 months after surgery
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Joong-Il Kim, MD, PhD, Hallym University Kangnam Sacred Heart Hospital
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- HKS 2026-05-024
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .